Siren, L.L.C. Caribou Biosciences, Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 105,347 shares of CRBU stock, worth $111,667. This represents 0.01% of its overall portfolio holdings.
Number of Shares
105,347
Previous 105,347
-0.0%
Holding current value
$111,667
Previous $206 Million
18.88%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
138Shares Held
54.4MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$7.36 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$4.84 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$4.11 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$2.91 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$2.65 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $64.5M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...